| 2-AG | 2-arachidonoylglycerol |
| Adv DMEM | Advanced Dulbecco’s Modified Eagle Medium |
| Adv DMEM F12 | Advanced Dulbecco’s Modified Eagle Medium F12 |
| AEA | Arachidonoylethanolamide or Anandamide |
| ATCC | American Type Culture Collection |
| BBB | Blood–Brain Barrier |
| CB1R | Cannabinoid Receptors 1 |
| CB2R | Cannabinoid Receptors 2 |
| CNS | Central Nervous System |
| DMEM | Dulbecco’s Modified Eagle’s Medium |
| EGM-2 | Endothelial Growth Medium-2 |
| Equisetum A.L. | Equisetum arvense L. |
| FAAH | Fatty Acid Amide Hydrolase |
| FBS | Foetal Bovine Serum |
| HBVPs | Primary Human Cerebral Vascular Pericytes |
| HUVEC | Human Umbilical Vein Endothelial Cells |
| IL-1β | Interleukin 1β |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| NAAA | N-acylethanolamine-hydrolyzing acid amidase |
| P/S | Penicillin–Streptomycin |
| PEA | palmitoylethanolamide |
| PEA-um | PEA Ultramicronized |
| PKA | Protein Kinase A |
| PKC | Protein Kinase C |
| PNS | Peripheral Nervous Systems |
| PPARα | Peroxisome Proliferator-Activated Receptor Alpha |
| pPKA | Phospho-Protein Kinase A |
| pTRPV1 | Phospho-Transient Receptor Potential Vanilloid 1 |
| ROS | Reactive Oxygen Species |
| RPMI | Roswell Park Memorial Institute medium |
| TJ | Tight Junction |
| TNFα | Tumour Necrosis Factor α |
| TRPV1 | Transient Receptor Potential Vanilloid 1 |